{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:18:23Z","timestamp":1790187503819,"version":"4.1.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/rhu.0b013e3181c8e176","type":"journal-article","created":{"date-parts":[[2009,12,26]],"date-time":"2009-12-26T03:20:57Z","timestamp":1261797657000},"page":"32-33","source":"Crossref","is-referenced-by-count":12,"title":["Cetuximab in the Treatment of Rheumatoid Arthritis"],"prefix":"10.1097","volume":"16","author":[{"given":"Timothy","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina G.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip W.","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Deeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 4","key":"R1-10-20210207","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0959-8049(01)00233-7","article-title":"The EGFR as a target for anticancer therapy\u2013focus on cetuximab.","volume":"37","author":"Baselga","year":"2001","journal-title":"Eur J Cancer"},{"key":"R2-10-20210207","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/ard.48.10.820","article-title":"Human epidermal growth factor for the stratification of synovial lining layer and neovascularization in rheumatoid arthritis.","volume":"48","author":"Shiozawa","year":"1989","journal-title":"Am Rheum Dis"},{"issue":"suppl 4","key":"R3-10-20210207","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0959-8049(01)00230-1","article-title":"The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities.","volume":"37","author":"Yarden","year":"2001","journal-title":"Eur J Cancer"},{"key":"R4-10-20210207","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-9255-5-5","article-title":"Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients.","volume":"5","author":"Yamane","year":"2008","journal-title":"J Inflamm (Lond)"},{"key":"R5-10-20210207","first-page":"1083","article-title":"Cell proliferation-related production of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin) by cultured human rheumatoid synovial fibroblasts.","volume":"27","author":"Hiraoka","year":"1992","journal-title":"Biochem Int"},{"key":"R6-10-20210207","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/03009740510017715","article-title":"TGF-alpha and ErbB2 production in synovial joint tissue: increased expression in arthritic joints.","volume":"34","author":"Hallbeck","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"R7-10-20210207","first-page":"859","article-title":"Immuno-reactive human epidermal growth factor (h-EGF) in rheumatoid synovial fluids.","volume":"67","author":"Kusada","year":"1993","journal-title":"Nippon Seikeigeka Gakkai Zasshi"},{"key":"R8-10-20210207","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/1529-0131(200102)44:2<260::AID-ANR42>3.0.CO;2-P","article-title":"Involvement of ErbB-2 in rheumatoid synovial cell growth.","volume":"44","author":"Satoh","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R9-10-20210207","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2249.2006.03067.x","article-title":"Imatinib mesylate inhibits proliferation of rheumatoid synovial fibroblast-like cells and phosphorylation of Gab adapter proteins activated by platelet-derived growth factor.","volume":"144","author":"Kameda","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"R10-10-20210207","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1158\/1078-0432.CCR-06-1726","article-title":"Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines.","volume":"13","author":"Kurai","year":"2007","journal-title":"Clin Cancer Res"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124743-201001000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:30Z","timestamp":1786039770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124743-201001000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3181c8e176","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}